333 related articles for article (PubMed ID: 16497946)
1. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model.
Kim SW; Han H; Chae GT; Lee SH; Bo S; Yoon JH; Lee YS; Lee KS; Park HK; Kang KS
Stem Cells; 2006 Jun; 24(6):1620-6. PubMed ID: 16497946
[TBL] [Abstract][Full Text] [Related]
2. Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical Efficacy.
Gupta PK; Krishna M; Chullikana A; Desai S; Murugesan R; Dutta S; Sarkar U; Raju R; Dhar A; Parakh R; Jeyaseelan L; Viswanathan P; Vellotare PK; Seetharam RN; Thej C; Rengasamy M; Balasubramanian S; Majumdar AS
Stem Cells Transl Med; 2017 Mar; 6(3):689-699. PubMed ID: 28297569
[TBL] [Abstract][Full Text] [Related]
3. [Transplantation of cord blood endothelial progenitor cells ameliorates limb ischemia].
Yang C; Zhang ZH; Lu SH; Yang RC; Qian GQ; Han ZC
Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(16):1437-41. PubMed ID: 14521750
[TBL] [Abstract][Full Text] [Related]
4. Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease).
Cacione DG; do Carmo Novaes F; Moreno DH
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012794. PubMed ID: 30378681
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic angiogenesis in Buerger's disease: reviewing the treatment landscape.
Ribieras AJ; Ortiz YY; Liu ZJ; Velazquez OC
Ther Adv Rare Dis; 2022; 3():26330040211070295. PubMed ID: 37180424
[TBL] [Abstract][Full Text] [Related]
6. Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease.
Saito Y; Sasaki K; Katsuda Y; Murohara T; Takeshita Y; Okazaki T; Arima K; Katsuki Y; Shintani S; Shimada T; Akashi H; Ikeda H; Imaizumi T
Circ J; 2007 Aug; 71(8):1187-92. PubMed ID: 17652879
[TBL] [Abstract][Full Text] [Related]
7. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results.
Isner JM; Baumgartner I; Rauh G; Schainfeld R; Blair R; Manor O; Razvi S; Symes JF
J Vasc Surg; 1998 Dec; 28(6):964-73; discussion 73-5. PubMed ID: 9845647
[TBL] [Abstract][Full Text] [Related]
8. Umbilical cord blood-derived aldehyde dehydrogenase-expressing progenitor cells promote recovery from acute ischemic injury.
Putman DM; Liu KY; Broughton HC; Bell GI; Hess DA
Stem Cells; 2012 Oct; 30(10):2248-60. PubMed ID: 22899443
[TBL] [Abstract][Full Text] [Related]
9. Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger's disease).
Swigris JJ; Olin JW; Mekhail NA
J Vasc Surg; 1999 May; 29(5):928-35. PubMed ID: 10231644
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of human umbilical cord-derived stem cells in ischemic diseases.
Wu KH; Zhou B; Mo XM; Cui B; Yu CT; Lu SH; Han ZC; Liu YL
Transplant Proc; 2007 Jun; 39(5):1620-2. PubMed ID: 17580202
[TBL] [Abstract][Full Text] [Related]
11. Early Results of Clinical Application of Autologous Whole Bone Marrow Stem Cell Transplantation for Critical Limb Ischemia with Buerger's Disease.
Heo SH; Park YS; Kang ES; Park KB; Do YS; Kang KS; Kim DI
Sci Rep; 2016 Jan; 6():19690. PubMed ID: 26791280
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
[TBL] [Abstract][Full Text] [Related]
13. Staged vascular reconstruction along with repeatedly performed angiography to prevent ischemic limb loss with Buerger's disease: report of a case.
Shindo S; Saka A; Kubota K; Kojima A; Ishimoto T; Iyori K; Kobayashi M; Kamiya K; Tada Y
Surg Today; 2001; 31(8):754-8. PubMed ID: 11510620
[TBL] [Abstract][Full Text] [Related]
14. Buerger's disease with multisystem involvement. A case report and a review of the literature.
Calgüneri M; Oztürk MA; Ay H; Arsava EM; Altinok D; Ertenli I; Kiraz S
Angiology; 2004; 55(3):325-8. PubMed ID: 15156267
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of extended endovascular recanalization of 16 consecutive Buerger's disease patients.
Kacmaz F; Kaya A; Keskin M; Keceoglu S; Algin IH; Yilmazkaya B; Ilkay E
Vascular; 2019 Jun; 27(3):233-241. PubMed ID: 30305010
[TBL] [Abstract][Full Text] [Related]
16. Combined growth factors enhanced angiogenic potential of cord blood-derived mononuclear cells transplanted to ischemic limbs.
Kim MH; Zhang HZ; Kim SW
J Mol Cell Cardiol; 2011 Nov; 51(5):702-12. PubMed ID: 21782826
[TBL] [Abstract][Full Text] [Related]
17. Thromboangiitis obliterans (Buerger's disease).
Klein-Weigel PF; Richter JG
Vasa; 2014 Sep; 43(5):337-46. PubMed ID: 25147010
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of erythropoietin gene-transfected umbilical cord mesenchymal stem cells as a treatment for limb ischemia in rats.
Li JP; Wang DW; Song QH
Genet Mol Res; 2015 Dec; 14(4):19005-15. PubMed ID: 26782551
[TBL] [Abstract][Full Text] [Related]
19. Thromboangiitis obliterans (Buerger's disease).
Olin JW; Shih A
Curr Opin Rheumatol; 2006 Jan; 18(1):18-24. PubMed ID: 16344615
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic criteria and treatment of Buerger's disease: a review.
Lazarides MK; Georgiadis GS; Papas TT; Nikolopoulos ES
Int J Low Extrem Wounds; 2006 Jun; 5(2):89-95. PubMed ID: 16698911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
